The new interdisciplinary research consortium "Chemical BioMedicine" (ChemBioMed) seeks to extract new materials from natural sources, such as fungi and deep-sea sponges, which could help dissect disease mechanisms and prevent illnesses.
The Carl Zeiss Foundation is supporting the innovative research collaboration between the University Medical Center Mainz and the Biology and Chemistry institutes of Johannes Gutenberg University Mainz (JGU) with €1 million. This sponsorship is being provided as part of the foundation's program "Promotion of University Research Structures."
Today it is mainly chemicals that are used worldwide for the prevention and treatment of illnesses such as cancer, Alzheimer's disease, and inflammatory disorders. However, natural products extracted from fungi or marine sponges used as sources of potential new active substances have a decisive advantage over purely synthetically-produced products: Evolution has already pre-tested them in living organisms.
Consequently, the new ChemBioMed project aims to develop a seamless research pipeline, starting with the extraction and identification of bioactive natural products, the analysis of their structure and synthesis, followed by the exploitation of their structure-activity relationship for appropriate biomedical applications. "To meet this ambitious challenge, we depend on exceptional minds as well as sophisticated technologies. So, physicians, chemists, biologists, and bioinformatics specialists need to join forces in the research concept," explains one of the two coordinators of the consortium, Professor Dr. Roland Stauber of the Department of Otolaryngology, Head, and Neck Surgery – Plastic Surgery at the Mainz University Medical Center.
It is often difficult to use natural products because of their complex structure, representing a major challenge for their synthesis, and because of their limited availability. "However, with our ample experience in the chemistry of natural products adopted over the last years we are now well prepared to overcome such obstacles," the second coordinator of the consortium, Professor Dr. Till Opatz of the Institute of Organic Chemistry and Director of the Natural Product Synthesis Center at JGU, continues.
In addition, the Institute of Biotechnology and Drug Research (IBWF) and the robotic platform at the Mainz Screening Center are major pillars promoting the workflow of the project. "Clearly, the current support by the Carl Zeiss Foundation has helped us reach a critical milestone, paving our road towards excellent research," summarizes Roland Stauber looking towards the future.
The Institute of Biotechnology and Drug Research (IBWF), cooperation partner in the Center of Natural Materials Research Rhineland-Palatinate – Center of Excellence in Integrated Natural Materials Research, is currently based in Kaiserslautern, but will soon be relocated to Johannes Gutenberg University Mainz. Among other things, the IBWF undertakes interdisciplinary, applied research with the aim of developing new active substances from natural sources. "We bring with us specialist knowledge and experience in the area of drug and natural materials research and look forward to cooperating and networking with the faculties of Biology, Chemistry, and Medicine at Mainz University to tap the scientific and economic potential," says PD. Dr. Eckhard Thines, Director of the IBWF and, from October 2012, Professor of Biotechnology and Drug Research at the Faculty of Biology at Mainz University.
Mainz University thus represents an ideal location for the new ChemBioMed project. Extensive contacts and the proximity to leading pharmaceutical companies will further help to efficiently combine fundamental and applied clinically-relevant research. Hence, JGU sees enormous scientific and economic potential in this research area – especially facing the increasing need for novel and more effective "chemical tools."
"A research concept of strategic importance has been promoted thanks to the support of the Carl Zeiss Foundation. This is another important step in establishing the Mainz science hub as an internationally important center for molecular medicine," states the Chief Scientific Officer of the Mainz University Medical Center, Professor Dr. Dr. Reinhard Urban.
"I especially welcome the intention that not only researchers but also students will benefit from this prestigious support. Because this future-oriented research concept complements our degree programs in Biomedical Chemistry, Biomedicine, and Applied Bioinformatics, it gives our students the chance to participate in research projects and applications at an early stage," says Professor Dr. Mechthild Dreyer, Vice President for Learning and Teaching at JGU. "This supports our concept of research-driven teaching and thus the integration of outstanding research and teaching as a quality hallmark of our university."
Further Reports about: biomedicine > Biotechnology > ChemBioMed > CHEMISTRY > Drug Delivery > Gates Foundation > IBWF > living organism > Medical Wellness > natural products > natural sources > Prostate Surgery > synthetic biology
More articles from Awards Funding:
Towards a better Internet: Computer science professors receive largest research award from the EU
12.12.2013 | Universität des Saarlandes
10 Million for Research: The University of Basel Receives four ERC Consolidator Grants
12.12.2013 | Universität Basel
A 12-year study of massive stars has reaffirmed that our Galaxy has four spiral arms, following years of debate sparked by images taken by NASA's Spitzer Space Telescope that only showed two arms.
The new research, which is published online today [17 December] in the Monthly Notices of the Royal Astronomical Society, is part of the RMS Survey, which was launched by academics at the University of Leeds.
Astronomers cannot see what our Galaxy, which is called the Milky Way, looks like because we ...
In collaboration with the University of Basel, an international team of researchers has observed a strong energy loss caused by frictional effects in the vicinity of charge density waves.
This may have practical significance in the control of nanoscale friction. The results have been published in the scientific journal Nature Materials.
Friction is often seen as an adverse phenomenon that leads to wear and causes energy loss. Conversely, however, too little friction can be a disadvantage as well – ...
A new type of transistor that could make possible fast and low-power computing devices for energy-constrained applications such as smart sensor networks, implantable medical electronics and ultra-mobile computing is feasible, according to Penn State researchers.
Called a near broken-gap tunnel field effect transistor (TFET), the new device uses the quantum mechanical tunneling of electrons through an ultrathin energy barrier to provide high current at low voltage.
Penn State, the National Institute of Standards and Technology and IQE, a specialty wafer manufacturer, jointly presented their findings at ...
The team of Johannes Zuber at the IMP in Vienna, Austria, managed to overcome remaining key limitations of RNA interference (RNAi) - a unique method to specifically shut off genes.
By using an optimized design, the scientists were able to inhibit genes with greatly enhanced efficiency and accuracy. The new method facilitates the search for drug targets and improves the interpretation of experimental results.
The IMP will make this „RNAi toolkit“ available to researchers. Results of the study are published in ...
Research The dangerous parasite Schistosoma mansoni that causes snail fever in humans could become significantly less common in the future a new international study led by researchers from the University of Copenhagen predicts.
The results are surprising because they contradict the general assumption that climate change leads to greater geographical spread of diseases. The explanation is that the parasite’s host snails stand to lose suitable habitat due to climate change.
“Our research shows that the expected effects of climate change will lead ...
18.12.2013 | Life Sciences
18.12.2013 | Medical Engineering
18.12.2013 | Studies and Analyses
11.12.2013 | Event News
10.12.2013 | Event News
05.12.2013 | Event News